Second Sight Medical Products (EYES) Scheduled to Post Quarterly Earnings on Tuesday

Second Sight Medical Products (NASDAQ:EYES) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, August 6th. Analysts expect the company to announce earnings of ($0.06) per share for the quarter.

Second Sight Medical Products (NASDAQ:EYES) last posted its quarterly earnings results on Wednesday, May 15th. The medical device company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.04). The company had revenue of $1.13 million during the quarter, compared to analysts’ expectations of $1.70 million. Second Sight Medical Products had a negative return on equity of 326.46% and a negative net margin of 497.18%. On average, analysts expect Second Sight Medical Products to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

EYES opened at $0.77 on Monday. The stock has a 50-day moving average of $0.80. The company has a current ratio of 4.71, a quick ratio of 4.50 and a debt-to-equity ratio of 0.09. The stock has a market cap of $99.50 million, a price-to-earnings ratio of -1.47 and a beta of 2.27. Second Sight Medical Products has a 1 year low of $0.63 and a 1 year high of $1.98.

EYES has been the subject of several recent analyst reports. Zacks Investment Research raised Second Sight Medical Products from a “sell” rating to a “hold” rating in a research report on Monday, June 17th. ValuEngine lowered Second Sight Medical Products from a “hold” rating to a “sell” rating in a research report on Tuesday, May 14th.

Second Sight Medical Products Company Profile

Second Sight Medical Products, Inc develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury.

Recommended Story: What is a back-end load?

Earnings History for Second Sight Medical Products (NASDAQ:EYES)

Receive News & Ratings for Second Sight Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Second Sight Medical Products and related companies with's FREE daily email newsletter.